Patients want their medical test results immediately, even when its bad news, survey finds
Fierce Healthcare
MARCH 22, 2023
Patients want their medical test results immediately, even when its bad news, survey finds hlandi Wed, 03/22/2023 - 12:13
patients news 
ICYMI: PBM exec admits choosing profits over patients
PhRMA
JUNE 2, 2023
With Congress discussing policy changes that would lower drug costs for patients and rein in powerful middlemen, insurers and their PBMs are dusting off their old playbook and once again threatening to increase costs for employers if required to do their job and actually provide meaningful coverage to patients.
Insurance 
306
306 Insurance 306
306 Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Patients Are Less Likely to Buy Generics After Receiving Bad News About Their Health
Pharmacy Times
JUNE 15, 2023
Negative findings may spur choice of brand-name drugs, despite expense.
123 
PDUFA and BsUFA reauthorizations are wins for patients
PhRMA
OCTOBER 5, 2022
That’s why the recently enacted Prescription Drug User Fee Act (PDUFA VII) and Biosimilar User Fee Act (BsUFA III) are both great news for biopharmaceutical innovation and for patients. Food & Drug Administration (FDA) to keep pace with the scientific advancements happening every day in labs across the country.
FDA 302
302 FDA 302
302 
HIMSS24: AWS, symplr collaborate on AI assistants to automate complex workflows, mundane tasks
Fierce Healthcare
MARCH 11, 2024
ORLANDO, Florida—HIMSS24 just kicked off today, and there's already a stream of AI innovation news. ORLANDO, Florida—Symplr is working with Amazon Web Services to develop AI assistants to help automate complex workflows and mundane tasks for healthcare workers and also power chatbots to help patients find and schedule the right care.
136 
After Amylyx ALS trial failure, patients share disappointment and fear — but some hope
STAT
MARCH 12, 2024
The news last week that a Phase 3 trial of Amylyx Pharmaceuticals’ amyotrophic lateral sclerosis drug — marketed as Relyvrio — failed to benefit patients compared to placebo hit the ALS patient community hard.
134 
Science Communication Tips for Pharmacists
Drug Topics
NOVEMBER 3, 2022
Pharmacists can help educate patients as they try to analyze scientific information shared via the news or social media.
Communication 200
200 Communication 200
200 
SMC approval welcome news for breast cancer patients
Pharma Times
MARCH 9, 2022
Trodelvy is accepted for use in mTNBC patients who have already received two or more systemic therapies
50 
STAT+: Gene-edited pig kidney transplanted into a living patient for the first time
STAT
MARCH 21, 2024
In a new test of xenotransplantation, a medical team at Massachusetts General Hospital announced Thursday that, for the first time, it had transplanted a kidney from a CRISPR gene-edited pig into a living patient. Surgeons performed the milestone procedure over four hours on Saturday, March 16, without complications.
Hospitals 145
145 Hospitals 145
145 
Between hope and despair: Improving cancer outcomes
PhRMA
JULY 11, 2023
I can still see everything in the hospital room in my mind’s eye, the night — 13 days before Christmas — a neurologist delivered the news to my mother and me that she had non-Hodgkin’s lymphoma, an aggressive tumor lodged in her brain.
Hospitals 184
184 Hospitals 184
184 
STAT+: Bone marrow transplant advance could widen use of this less buzzy cure for sickle cell disease
STAT
DECEMBER 12, 2023
SAN DIEGO — The sickle cell community has for the past few days been buzzing with news of the first-ever approved gene therapies for the devastating disease. By comparison, a bone marrow transplant costs about $200,000 to $400,000, and, the study’s authors argue, could be performed on a broader swath of patients.
Chemotherapy 122
122 
STAT+: More patients are getting their meds online. Big Pharma wants in on the action
STAT
JANUARY 17, 2024
Since the pandemic, patients have become increasingly comfortable with getting their medications online. In early January, Eli Lilly announced a platform that allows patients to access and fill prescriptions for its drugs online, timing the news to the availability of its obesity medication Zepbound.
135 
STAT+: Verve Therapeutics ‘pauses’ tests of its gene editor for heart disease and prioritizes a backup treatment
STAT
APRIL 2, 2024
Verve Therapeutics said Tuesday that it is pausing testing of its closely watched gene-editing treatment for high cholesterol after a patient receiving the drug experienced elevated liver enzymes and low platelet levels.
Compounding 119
119 Compounding 119
119 
In partial reversal, Texas Medicaid greenlights first step in gene therapy for Afghan refugees’ infant son
STAT
JANUARY 11, 2024
The Pashai family of Dallas on Thursday got some good news, but not exactly the news they had spent the last month praying for. “It’s a victory but it’s a small victory,” said Maria Kefalas, a patient advocate with the Calliope Joy Foundation, which has been mobilizing support for the Pashais.
107 
Listen: A dilemma in ALS, the first MASH drug, & why gene therapy is hard
STAT
MARCH 14, 2024
Why don’t patients want gene therapy? We also discuss the latest news in the life sciences, including a tepid reception for gene therapies, the future of CAR-T cancer treatment, and the first approved medicine for a prevalent liver disease. What happens when an approved drug doesn’t work? And is MASH still a big deal?
117 
STAT+: Amylyx ALS drug failure leaves patients, advocates, and researchers reeling — and wondering what’s next
STAT
MARCH 8, 2024
The latest disappointment in amyotrophic lateral sclerosis research brought crushing news for patients and physicians, forcing the community to consider just what to do with an approved medicine that doesn’t appear to work.
FDA 145
145 FDA 145
145 
STAT+: Argenx readies another blockbuster opportunity with its antibody drug
STAT
MARCH 14, 2024
Have you heard the news? I’m launching a weekly email newsletter starting on March 28. It’s called Adam’s Biotech Scorecard and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week?
126 
STAT+: Historic approval of sickle cell gene therapies met with cautious optimism by experts at ASH
STAT
DECEMBER 9, 2023
SAN DIEGO — News of the Food and Drug Administration’s historic approval of the first gene therapies for sickle cell disease sparked discussion, debate, and, above all, measured optimism at this year’s meeting of the American Society of Hematology. Jude Children’s Research Hospital. I remain skeptical.”
Hospitals 140
140 Hospitals 140
140 
STAT+: Patients wants test results now, and radiologists need time to explain. Can they meet in the middle?
STAT
DECEMBER 1, 2023
Sometimes it takes days, or even weeks, for medical imaging results to be analyzed by a radiologist, transferred to a primary doctor, and then delivered to the patient — good news or bad. Today, that hand-wringing delay has been nearly eliminated.
115 
The U.K. just cleared a drug to prevent breast cancer. U.S. women may not know it’s already an option
STAT
NOVEMBER 13, 2023
The news that the U.K. But the fact that a patient in her breast cancer prevention clinic hadn’t ever heard of such a possibility before was. has approved a preventive drug for post-menopausal women at risk of developing breast cancer wasn’t a shock to breast medical oncologist Abenaa Brewster.
FDA 141
141 FDA 141
141 
Opinion: How to save the U.S. News & World Report Best Hospitals rankings
STAT
AUGUST 24, 2023
News & World Report recently issued its 2023-24 Best Hospitals ratings. News process, while some hospitals have expressed their desire to abandon the rankings as well. Now is the time for health care ratings to offer patients transparent and useful measures of quality that enable informed choices.
Hospitals 95
95 
STAT+: Maze CEO ‘personally disappointed’ in Sanofi decision to terminate partnership
STAT
DECEMBER 12, 2023
When Sanofi terminated its partnership with Maze Therapeutics this week to develop an experimental drug for Pompe disease, Maze CEO Jason Coloma did not learn the news in a conference call with the French pharma giant or even an email. He found out when Sanofi issued a public statement. Responding to the U.S.
117 
STAT+: Pharmalittle: We’re reading about Cigna biosimilar plans, a Vertex deal in South Africa, and more
STAT
APRIL 26, 2024
Or you could hold your breath and spend time catching up on the news of the world. … Cigna plans to make copies of AbbVie’s Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S. Overall, antibiotic use did not improve clinical outcomes for patients with Covid-19.
Are FDA drug recalls important?
OctariusRx
MARCH 25, 2024
If so, what steps should you take to ensure your patients are safe and your facility is maintaining regulatory compliance? You may hear about them on the evening news or get a notice from a drug company/distributor, or even see it posted on social media. Are FDA drug recalls important? Do you need to take them seriously?
FDA 75
75 FDA 75
75 
Opinion: We tried to quantify how harmful hospital ransomware attacks are for patients. Here’s what we found
STAT
NOVEMBER 17, 2023
This article is part of a partnership between First Opinion and Tradeoffs, a nonprofit news organization exploring our confusing, costly, and often counterintuitive health care system. To Manchester Memorial had to ask ambulances to take emergency patients elsewhere. What happened next is the stuff of nightmares.
Hospitals 118
118 Hospitals 118
118 
Watch DSN: Walgreens pharmacists on the frontlines of patient testing services
Drug Store News
FEBRUARY 21, 2023
Drug Store News interviewed Anita Patel, vice president of pharmacy services development at Walgreens, about how the retailer is utilizing pharmacists in patient care and testing.
Patient Care 97
97 Patient Care 97
97 
How to spot when drug companies spin clinical trial results
STAT
NOVEMBER 28, 2023
Investors , analysts, doctors, and even patients face an avalanche of news from biotech companies about their human trials of experimental drugs, and wading through all that data to draw reasonable conclusions is a challenging task.
134 
Watch DSN: How digital tools are transforming pharmacists into stewards of community health
Drug Store News
MARCH 21, 2023
Drug Store News interviewed Brian Owens, Senior Vice President, Commerce Strategy VMLY&R, about how pharmacists can use digital tools to reach more patients to promote healthy behaviors, improve health outcomes and increase the paths of purchase to O
98 
NICE recommends Roche biologic for lymphoma
European Pharmaceutical Review
OCTOBER 17, 2023
A novel treatment option for lymphoma Helen Knight, Director of Medicines Evaluation remarked that it “such good news” that glofitamab was found to be clinically and cost effective for treating people with this advanced form of cancer. NICE “welcome the news that NHS England will make this available to patients quickly,” Knight added.
FDA 105
105 FDA 105
105 
STAT+: In early glimpse at data, Akili’s video game shows positive results with adults with ADHD
STAT
MAY 3, 2023
That’s very good news for a company that’s racing to reach more patients in hopes of building a sustainable business. Akili Interactive on Wednesday revealed earlier-than-expected top-line clinical trial results suggesting its video game treatment for attention deficit hyperactivity disorder is effective for adults.
104 
GLP-1 Agonists and Gastroparesis
Med Ed 101
AUGUST 9, 2023
After being heralded as the next savior in weight loss by the media, the GLP-1 Agonists/GIP agonists have come under more scrutiny lately in the news. A recent article on CNN details patients who […] The post GLP-1 Agonists and Gastroparesis appeared first on Med Ed 101.
98 
Opinion: Every smartphone should have an app to connect to 988, the mental health crisis line
STAT
SEPTEMBER 22, 2023
At the height of the pandemic, when everything was shut down, a patient with whom I had a long-term relationship developed suicidal ideation. The good news was that I could still have used this bricked phone to call 911 in the event of an emergency. And he was ashamed to use his parents’ telephone because of privacy issues.
139 
Listen: Sarepta’s pivotal moment, biotech’s big week, & the future of Covid boosters
STAT
APRIL 20, 2023
Our colleague Helen Branswell joins us to explain the latest news on Covid-19 boosters and the implications of a Marburg outbreak in Equatorial Guinea. Then we dive into the long history of a gene therapy from Sarepta Therapeutics, a polarizing medicine that promises to change the lives of patients with Duchenne muscular dystrophy.
Vaccines 97
97 Vaccines 97
97 
Pharma á la carte – 05/04/2023
The Honest Apothecary
MAY 3, 2023
Here I share some of the latest news, articles, editorials, or blog posts that fall generally under the theme of Pharma or healthcare. Minnesota vs. CVS Pharmacy CVS Caremark has been sued by the state of Minnesota for allegedly steering patients to their own retail pharmacies. ” STAT NEWS. . ” STAT NEWS.
STAT+: A spending frenzy on obesity drugs
STAT
APRIL 24, 2024
Today we have some developments about Novo Nordisk’s insulin business, a side of the company that people don’t really talk about anymore, and some news about their GLP-1 business, a side that people can’t stop talking about. Good morning! Adjusted earnings were $3.67 on total revenue of $2.29
81 
STAT+: After promising early data, gene therapy trial for Huntington’s takes puzzling turn
STAT
JUNE 21, 2023
Last year, after a string of high-profile trial failures , the Huntington’s disease community got positive news in the form of very early data from an experimental gene therapy for the rare neurodegenerative condition.
133 
STAT+: FDA panel endorses Alnylam’s heart drug — after picking apart its supporting data
STAT
SEPTEMBER 13, 2023
A group of advisers to the Food and Drug Administration voted in favor of Alnylam Pharmaceuticals’ treatment for a debilitating heart disease Wednesday, but only after a day-long debate challenging whether the drug’s modest observed effects were actually meaningful for patients.
FDA 125
125 FDA 125
125 
‘This is a nonpartisan issue’: Planned Parenthood’s Alexis McGill Johnson on fighting for reproductive rights
STAT
MARCH 14, 2023
Wade, the news has been full of stories about patients crossing state lines in order to access reproductive care. “I had a patient travel all the way from Mississippi,” said Sarah Traxler, an OB-GYN in Minnesota, “only for me to have to say, ‘It’s not safe for me to see you here in this clinic.
Hospitals 100
100 Hospitals 100
100 
STAT+: New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
STAT
MAY 4, 2023
WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.
FDA 98
98 FDA 98
98 
‘I’m terrified’: Patients scramble for treatment after 13 ketamine clinics shut down
STAT
MARCH 17, 2023
The message went out to some patients and to all of the employees of his company’s clinics across nine states — what had, up until moments before, been one of the largest ketamine clinic chains in the country. To patients, the news came as a complete shock. To patients, the news came as a complete shock.
111 
Pharmacy Guild accused in Senate of using patient contact details to protest Labor dispensing changes
The Guardian - Pharmaceutical Industry
JUNE 8, 2023
Meanwhile, the Australian Medical Association has labelled the Pharmacy Guild’s opposition to the new rules a “sick joke”. Meanwhile, the Australian Medical Association has labelled the Pharmacy Guild’s opposition to the new rules a “sick joke”.
Labelling 61
61 Labelling 61
61 
Counterfeit diabetes pens identified in EU and UK
European Pharmaceutical Review
OCTOBER 19, 2023
Ozempic: supply and falsification issues News of the falsified diabetes pen arrived as there has been heightened demand for the medicine. News of the falsified diabetes pen arrived as there has been heightened demand for the medicine. This has resulted in a supply shortage, EMA highlighted.
Labelling 100
100 Labelling 100
100 
Two-for-one prescriptions for patients a ‘kick in the guts’ for Australian pharmacies, guild claims
The Guardian - Pharmaceutical Industry
APRIL 25, 2023
The opposition leader, Peter Dutton, has already lent support for the campaign, encouraging patients to ask pharmacists how “the proposed changes will impact you as a customer and them as a local small business”. Sign up for Guardian Australia’s free morning and afternoon email newsletters for your daily news roundup Continue reading.
54 
STAT+: UPMC, Advocate Aurora, Duke fighting lawsuits over use of Meta’s tracking tool
STAT
NOVEMBER 23, 2022
Five months after a media investigation revealed that hospitals were feeding Meta sensitive patient information through a tracking tool on their websites, prominent systems like UPMC, Advocate Aurora, and Duke Health are still contending with the resulting legal action.
Hospitals 103
103 Hospitals 103
103 
Let's personalize your content